INVIVOGEN

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 5250
 
 
 
C07D HETEROCYCLIC COMPOUNDS 2160
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 2204
 
 
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 169
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198
 
 
 
C07K PEPTIDES 1135
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 1166

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0340,658 COMBINED USE OF A CHEMOTHERAPEUTIC AGENT AND A CYCLIC DINUCLEOTIDE FOR CANCER TREATMENTDec 09, 15Nov 30, 17[A61K]
2015/0037,819 ANTI-HLA MONOCLONAL CHIMERIC IMMUNOGLOBULIN, METHOD AND KIT IMPLEMENTING SUCH A MONOCLONAL CHIMERIC IMMUNOGLOBULINFeb 15, 13Feb 05, 15[G01N]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9637538 Anti-HLA monoclonal chimeric immunoglobulin, process and kit employing such a monoclonal chimeric immunoglobulinApr 24, 13May 02, 17[G01N, C07K]
9567336 Conjugated TLR7 and/or TLR8 and TLR2 agonistsMar 15, 13Feb 14, 17[A61K, C07D]
9458184 Compositions of TLR7 and/or TLR8 agonists conjugated to lipidsMar 15, 13Oct 04, 16[A61K, C07F, C07D, C07J]
9295732 Conjugated TLR7 and/or TLR8 and TLR2 polycationic agonistsFeb 22, 13Mar 29, 16[A61K]
8435777 CPG-free gene for a new secreted reporter proteinJan 20, 12May 07, 13[C12N]

Expired/Abandoned/Withdrawn Patents

  • No Patents to Display

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.